INCY
Incyte Corporation
NASDAQ: INCY · HEALTHCARE · BIOTECHNOLOGY
$99.10
+1.39% today
Updated 2026-04-29
Market cap
$19.80B
P/E ratio
14.00
P/S ratio
3.69x
EPS (TTM)
$7.08
Dividend yield
—
52W range
$58 – $112
Volume
1.6M
Incyte Corporation (INCY) Insider transactions
Net insider activity
Net buying (70,820 shares)
Buy transactions
46
Sell transactions
54
All transactions
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-04-17 | CAGNONI, PABLO J | President, Global Head of R&D | Sale | 12,590 | — | — |
| 2026-04-17 | CAGNONI, PABLO J | President, Global Head of R&D | Sale | 6,077 | — | — |
| 2026-04-17 | CAGNONI, PABLO J | President, Global Head of R&D | Sale | 18,667 | $96.50 | $1.80M |
| 2026-04-17 | CAGNONI, PABLO J | President, Global Head of R&D | Buy | 12,590 | $71.93 | $905598.70 |
| 2026-04-17 | CAGNONI, PABLO J | President, Global Head of R&D | Buy | 6,077 | $64.25 | $390447.25 |
| 2026-04-15 | STEIN, STEVEN H | CMO & Head of Late-Stage Dev. | Buy | 39,049 | — | — |
| 2026-04-15 | MEURY, WILLIAM | Director, Chief Executive Officer, President | Buy | 125,000 | — | — |
| 2026-04-15 | CAGNONI, PABLO J | President, Global Head of R&D | Buy | 27,892 | — | — |
| 2026-03-31 | HARRIGAN, EDMUND | Director | Buy | 269 | $94.12 | $25318.28 |
| 2026-03-31 | CLANCY, PAUL J | Director | Buy | 265 | $94.12 | $24941.80 |
| 2026-03-31 | BAKER, BROS. ADVISORS LP | Director, 10% Owner | Buy | 421 | — | — |
| 2026-03-25 | TROTTA, MATTEO | EVP, GM, Dermatology US | Sale | 537 | $92.23 | $49527.51 |
| 2026-03-17 | CAGNONI, PABLO J | President, R&D | Sale | 11,501 | — | — |
| 2026-03-17 | CAGNONI, PABLO J | President, R&D | Sale | 7,166 | — | — |
| 2026-03-17 | CAGNONI, PABLO J | President, R&D | Sale | 18,667 | $94.24 | $1.76M |
| 2026-03-17 | CAGNONI, PABLO J | President, R&D | Buy | 11,501 | $64.25 | $738939.25 |
| 2026-03-17 | CAGNONI, PABLO J | President, R&D | Buy | 7,166 | $61.18 | $438415.88 |
| 2026-02-19 | CAGNONI, PABLO J | President, R&D | Sale | 13,093 | — | — |
| 2026-02-19 | CAGNONI, PABLO J | President, R&D | Sale | 5,575 | — | — |
| 2026-02-19 | CAGNONI, PABLO J | President, R&D | Sale | 18,668 | $100.91 | $1.88M |
| 2026-02-19 | CAGNONI, PABLO J | President, R&D | Buy | 13,093 | $61.76 | $808623.68 |
| 2026-02-19 | CAGNONI, PABLO J | President, R&D | Buy | 5,575 | $61.18 | $341078.50 |
| 2026-02-02 | MORRISSEY, MICHAEL JAMES | EVP, Head of Tech. Operations | Sale | 185 | $102.67 | $18993.95 |
| 2026-02-02 | HEESON, LEE | EVP, Head of Incyte Intl | Sale | 111 | $102.67 | $11396.37 |
| 2026-01-20 | MORRISSEY, MICHAEL JAMES | EVP, Head of Tech. Operations | Sale | 429 | $102.62 | $44023.98 |
| 2026-01-16 | TROTTA, MATTEO | EVP, GM, Dermatology US | Buy | 8,542 | — | — |
| 2026-01-16 | TRAY, THOMAS | Principal Accounting Officer | Buy | 2,425 | — | — |
| 2026-01-16 | STEIN, STEVEN H | EVP & Chief Medical Officer | Buy | 19,932 | — | — |
| 2026-01-16 | MORRISSEY, MICHAEL JAMES | EVP, Head of Tech. Operations | Buy | 7,426 | — | — |
| 2026-01-16 | MAYES, PATRICK A | EVP & Chief Scientific Officer | Buy | 4,218 | — | — |
| 2026-01-16 | ISSA, MOHAMED KHAIRIE | EVP, Head of US Oncology | Buy | 14,237 | — | — |
| 2026-01-16 | HEESON, LEE | EVP, Head of Incyte Intl | Buy | 8,911 | — | — |
| 2026-01-16 | CAGNONI, PABLO J | President, R&D | Buy | 28,475 | — | — |
| 2026-01-07 | ISSA, MOHAMED KHAIRIE | EVP, Head of US Oncology | Sale | 10,856 | $109.07 | $1.18M |
| 2026-01-06 | ISSA, MOHAMED KHAIRIE | EVP, Head of US Oncology | Sale | 8,264 | $106.66 | $881438.24 |
| 2026-01-05 | STEIN, STEVEN H | EVP & Chief Medical Officer | Sale | 15,634 | $101.70 | $1.59M |
| 2025-12-31 | STEIN, STEVEN H | EVP & Chief Medical Officer | Sale | 13,292 | $98.77 | $1.31M |
| 2025-12-31 | MORRISSEY, MICHAEL JAMES | EVP, Head of Tech. Operations | Sale | 254 | $98.77 | $25087.58 |
| 2025-12-31 | HARRIGAN, EDMUND | Director | Buy | 245 | $98.77 | $24198.65 |
| 2025-12-31 | CLANCY, PAUL J | Director | Buy | 241 | $98.77 | $23803.57 |
| 2025-12-31 | BAKER, BROS. ADVISORS LP | Director, 10% Owner | Buy | 328 | — | — |
| 2025-12-19 | TRAY, THOMAS | Principal Accounting Officer | Sale | 1,730 | — | — |
| 2025-12-19 | TRAY, THOMAS | Principal Accounting Officer | Sale | 1,044 | — | — |
| 2025-12-19 | TRAY, THOMAS | Principal Accounting Officer | Sale | 2,774 | $100.00 | $277400.00 |
| 2025-12-19 | TRAY, THOMAS | Principal Accounting Officer | Buy | 1,730 | $95.76 | $165664.80 |
| 2025-12-19 | TRAY, THOMAS | Principal Accounting Officer | Buy | 1,044 | $95.76 | $99973.44 |
| 2025-12-18 | TRAY, THOMAS | Principal Accounting Officer | Sale | 600 | $98.25 | $58950.00 |
| 2025-12-17 | MORRISSEY, MICHAEL JAMES | EVP, Head of Tech. Operations | Sale | 4,323 | $97.26 | $420454.98 |
| 2025-12-16 | MORRISSEY, MICHAEL JAMES | EVP, Head of Tech. Operations | Sale | 53,175 | $97.29 | $5.17M |
| 2025-12-16 | MORRISSEY, MICHAEL JAMES | EVP, Head of Tech. Operations | Sale | 833 | $97.42 | $81150.86 |
| 2025-12-11 | MAYES, PATRICK A | EVP & Chief Scientific Officer | Sale | 255 | $94.94 | $24209.70 |
| 2025-12-10 | MAYES, PATRICK A | EVP & Chief Scientific Officer | Sale | 5,553 | $95.58 | $530755.74 |
| 2025-12-08 | HOPPENOT, HERVE | Director | Sale | 2,843 | $96.70 | $274918.10 |
| 2025-12-02 | STEIN, STEVEN H | EVP & Chief Medical Officer | Sale | 20,105 | $102.51 | $2.06M |
| 2025-12-01 | STEIN, STEVEN H | EVP & Chief Medical Officer | Sale | 17,093 | $102.04 | $1.74M |
| 2025-12-01 | STEIN, STEVEN H | EVP & Chief Medical Officer | Sale | 2,559 | $102.96 | $263474.64 |
| 2025-12-01 | MORRISSEY, MICHAEL JAMES | EVP, Head of Tech. Operations | Sale | 326 | $102.04 | $33265.04 |
| 2025-12-01 | HOFFMAN, RICHARD A. | EVP & General Counsel | Buy | 23,665 | — | — |
| 2025-12-01 | HOFFMAN, RICHARD A. | EVP & General Counsel | Buy | 43,301 | — | — |
| 2025-12-01 | HOFFMAN, RICHARD A. | EVP & General Counsel | Buy | 9,466 | — | — |
| 2025-11-24 | TRAY, THOMAS | Principal Accounting Officer | Sale | 600 | $103.00 | $61800.00 |
| 2025-11-21 | TRAY, THOMAS | Principal Accounting Officer | Sale | 169 | $102.00 | $17238.00 |
| 2025-11-17 | DENTON, SHEILA A. | EVP & General Counsel | Sale | 278 | — | — |
| 2025-11-17 | DENTON, SHEILA A. | EVP & General Counsel | Buy | 278 | $64.25 | $17861.50 |
| 2025-11-10 | HOPPENOT, HERVE | Director | Sale | 187,500 | $105.46 | $19.77M |
| 2025-11-05 | STEIN, STEVEN H | EVP & Chief Medical Officer | Sale | 2,995 | — | — |
| 2025-11-05 | STEIN, STEVEN H | EVP & Chief Medical Officer | Sale | 1,194 | — | — |
| 2025-11-05 | STEIN, STEVEN H | EVP & Chief Medical Officer | Sale | 1,044 | — | — |
| 2025-11-05 | STEIN, STEVEN H | EVP & Chief Medical Officer | Sale | 5,233 | $102.20 | $534812.60 |
| 2025-11-05 | STEIN, STEVEN H | EVP & Chief Medical Officer | Buy | 2,995 | $95.76 | $286801.20 |
| 2025-11-05 | STEIN, STEVEN H | EVP & Chief Medical Officer | Buy | 1,194 | $83.83 | $100093.02 |
| 2025-11-05 | STEIN, STEVEN H | EVP & Chief Medical Officer | Buy | 1,044 | $95.76 | $99973.44 |
| 2025-11-04 | DENTON, SHEILA A. | EVP & General Counsel | Sale | 598 | — | — |
| 2025-11-04 | DENTON, SHEILA A. | EVP & General Counsel | Buy | 598 | $58.06 | $34719.88 |
| 2025-11-03 | HEESON, LEE | EVP, Head of Incyte Intl | Sale | 3,074 | $94.02 | $289017.48 |
| 2025-10-15 | DENTON, SHEILA A. | EVP & General Counsel | Sale | 277 | — | — |
| 2025-10-15 | DENTON, SHEILA A. | EVP & General Counsel | Sale | 277 | $85.13 | $23581.01 |
| 2025-10-03 | DENTON, SHEILA A. | EVP & General Counsel | Sale | 3,501 | $85.54 | $299475.54 |
| 2025-10-02 | DENTON, SHEILA A. | EVP & General Counsel | Sale | 599 | — | — |
| 2025-10-02 | DENTON, SHEILA A. | EVP & General Counsel | Sale | 3,130 | $86.28 | $270056.40 |
| 2025-10-02 | DENTON, SHEILA A. | EVP & General Counsel | Buy | 599 | $58.06 | $34777.94 |
| 2025-10-01 | MAYES, PATRICK A | EVP & Chief Scientific Officer | Sale | 1,569 | $86.70 | $136032.30 |
| 2025-10-01 | HEESON, LEE | EVP, Head of Incyte Intl | Sale | 463 | $86.70 | $40142.10 |
| 2025-09-30 | HARRIGAN, EDMUND | Director | Buy | 289 | $84.81 | $24510.09 |
| 2025-09-30 | CLANCY, PAUL J | Director | Buy | 285 | $84.81 | $24170.85 |
| 2025-09-30 | BAKER, BROS. ADVISORS LP | Director, 10% Owner | Buy | 388 | — | — |
| 2025-09-22 | GARDNER, DAVID H | EVP, Chief Strategy Officer | Buy | 23,573 | — | — |
| 2025-09-22 | GARDNER, DAVID H | EVP, Chief Strategy Officer | Buy | 42,899 | — | — |
| 2025-09-22 | GARDNER, DAVID H | EVP, Chief Strategy Officer | Buy | 9,429 | — | — |
| 2025-09-16 | DENTON, SHEILA A. | EVP & General Counsel | Sale | 278 | — | — |
| 2025-09-16 | DENTON, SHEILA A. | EVP & General Counsel | Sale | 278 | $83.15 | $23115.70 |
| 2025-09-02 | DENTON, SHEILA A. | EVP & General Counsel | Sale | 598 | — | — |
| 2025-09-02 | DENTON, SHEILA A. | EVP & General Counsel | Buy | 598 | $58.06 | $34719.88 |
| 2025-08-25 | BASI, RAMITPAL K | EVP, Human Resources | Buy | 16,265 | — | — |
| 2025-08-25 | BASI, RAMITPAL K | EVP, Human Resources | Buy | 29,230 | — | — |
| 2025-08-25 | BASI, RAMITPAL K | EVP, Human Resources | Buy | 6,506 | — | — |
| 2025-08-15 | DENTON, SHEILA A. | EVP & General Counsel | Sale | 277 | — | — |
| 2025-08-15 | DENTON, SHEILA A. | EVP & General Counsel | Buy | 277 | $64.25 | $17797.25 |
| 2025-08-04 | DENTON, SHEILA A. | EVP & General Counsel | Sale | 598 | — | — |
| 2025-08-04 | DENTON, SHEILA A. | EVP & General Counsel | Buy | 598 | $58.06 | $34719.88 |